Comments on ICER’s Draft Evidence Report: Modulator Treatments for Cystic Fibrosis
March 16, 2020
Cystic fibrosis is a devastating disease that severely restricts patients’ quality of life and is associated with a shorter lifespan. The economic costs for managing cystic fibrosis are high. According to the American Thoracic Society, the average cost of care for cystic fibrosis was $48,000 in 2006. A good deal of these costs are costs associated with hospitalization.
Categorized in: Analysis